SaverOne 2014 Ltd.
For the period ended Dec 31, 2024. Filed Mar 21, 2025.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2024 · Filed Mar 21, 2025
SVRE$0.83+15.9%Stored close · as of Nov 6, 2026
Contents
Statements of changes in shareholders’ equity
| Note | Share capital and premium | Capital reserve in respect of share-based payment | Accumulated deficit | Total shareholders’ equity | |
|---|---|---|---|---|---|
| Balance as of December 31, 2021 | 80,440 | 8,425 | (76,813) | 12,052 | |
| Share-based payment to employees | 14 | - | 1,157 | - | 1,157 |
| Share-based payment to service provider | 13C1 | - | 1,056 | - | 1,056 |
| Partial exercise of over-allotment option into warrants | 13C1 | - | (158) | - | (158) |
| Expiration of over-allotment option | 13C1 | 435 | (435) | - | - |
| Net proceeds allocated to ADSs and prefunded warrants through initial public offering | 13C1 | 32,268 | - | - | 32,268 |
| Net proceeds received from issuance of ADSs through private placement transaction | 13C2 | 5,141 | - | - | 5,141 |
| Comprehensive loss for the year | - | - | (24,962) | (24,962) | |
| Balance as of December 31, 2022 | 118,284 | 10,045 | (101,775) | 26,554 | |
| Share-based payment to employees | 14 | - | 978 | - | 978 |
| Net proceeds allocated to ADSs issued as Commitment Shares in transaction of equity line | 13C3 | 87 | - | - | 87 |
| Issuance of ADSs resulted from partial exercise of Commitment Amount under equity line | 13C3 | 9,670 | - | - | 9,670 |
| Repayment of first promissory note (principal and interest) through issuance of ADSs resulted from partial exercise of Commitment Amount under equity line | 13C3 | 3,433 | - | - | 3,433 |
| Net proceeds received from issuance of ADSs as part of shelf prospectus through public offering transaction | 13C4 | 3,685 | - | - | 3,685 |
| Exercise of restricted share units into ordinary shares | 13C6 | 84 | (84) | - | - |
| Comprehensive loss for the year | - | - | (33,835) | (33,835) | |
| Balance as of December 31, 2023 | 135,243 | 10,939 | (135,610) | 10,572 | |
| Share-based payment to employees | 14 | - | 598 | - | 598 |
| Issuance of ADSs resulted from partial exercise of Commitment Amount under equity line | 13C3, 13C5 | 17,403 | - | - | 17,403 |
| Repayment of promissory notes (principal and interest) through issuance of ADSs resulted from partial exercise of Commitment Amount under equity line | 13C3 | 12,773 | - | - | 12,773 |
| Net proceeds received from issuance of ADSs as part of shelf prospectus through public offering transaction | 13C4 | 4,222 | - | - | 4,222 |
| Exercise of restricted share units into ordinary shares | 13C6 | 308 | (308) | - | - |
| Comprehensive loss for the year | - | - | (34,938) | (34,938) | |
| Balance as of December 31, 2024 | 169,949 | 11,229 | (170,548) | 10,630 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.